Roberta Melander

Associate Research Professor

252 Mccourtney Hall
Notre Dame, IN 46556


Research Areas

  • Biochemistry

Research Specialties

  • Medicine

Prospective Graduate Students

Request More Information


Year Title
2018-present Associate Research Professor, University of Notre Dame
2011-present Editor, Chemical Biology and Drug Design
2011-2018 Research Assistant Professor, North Carolina State University
2009-2011 Postdoctoral Research Associate, North Carolina State University
2008-2009 Postdoctoral Research Associate, University College London
2008 Ph.D. in Biological Chemistry, University of Manchester
2004 M.Chem. in Medicinal Chemistry, University of Manchester Institute of Science and Technology

Research Interests

My research centers on using small molecules to study and control bacterial behaviors. I am interested in developing molecules that mediate: antibiotic resistance and tolerance, evolution of resistance to antimicrobial agents, and virulence, as potential novel therapeutic options for treating bacterial infections. I am also working to identify molecules that influence secondary metabolite production to identify novel antimicrobials.

Selected Publications

  • Nemeth, A. M.; Young, M. M.; Melander, R. J.; Smith, R. D.; Ernst, R. K. and Melander, C. "Identification of a 2-Aminobenzimidazole Scaffold that Potentiates Gram-Positive Selective Antibiotics Against Gram-Negative Bacteria" 2024 ChemBioChem, 25 (8), e202400127. DOI: 10.1002/cbic.202400127.
  • Li, H. T.; Nemeth, A. M.; Melander, R. J. and Melander, C. "Synthesis, Stereochemical Resolution, and Analogue Synthesis of Variabiline, an Aporphine Alkaloid that Sensitizes Acinetobacter Baumannii and Klebsiella Pneumoniae to Colistin" 2024 ACS Infectious Diseases, 10 (4), pp.1339-1350. DOI: 10.1021/acsinfecdis.4c00026.
  • Crotteau, A. N.; Hubble, V. B.; Marrujo, S. A.; Mattingly, A. E.; Melander, R. J. and Melander, C. "Sensitization of Gram-Negative Bacteria to Aminoglycosides with 2-Aminoimidazole Adjuvants" 2023 Antibiotics-Basel, 12 (11), 1563. DOI: 10.3390/antibiotics12111563.
  • Harper, E. I.; Siroky, M. D.; Hilliard, T. S.; Dominique, G. M.; Hammond, C.; Liu, Y. Y.; Yang, J.; Hubble, V. B.; Walsh, D. J.; Melander, R. J.; Melander, C.; Ravosa, M. J. and Stack, M. S. "Advanced Glycation End Products as a Potential Target for Restructuring the Ovarian Cancer Microenvironment: A Pilot Study" 2023 International Journal of Molecular Sciences, 24 (12), 9804. DOI: 10.3390/ijms24129804.
  • Liu, C.; Zhang, H.; Peng, X.; Blackledge, M. S.; Furlani, R. E.; Li, H. T.; Su, Z. M.; Melander, R. J.; Melander, C.; Michalek, S. and Wu, H. "Small Molecule Attenuates Bacterial Virulence by Targeting Conserved Response Regulator" 2023 mBio, 14 (3), e00137-23. DOI: 10.1128/mbio.00137-23.
  • Marrujo, S. A.; Hubble, V. B.; Yang, J. D.; Wang, M.; Nemeth, A. M.; Barlock, S. L.; Juarez, D.; Smith, R. D.; Melander, R. J.; Ernst, R. K.; Chang, M. Y. and Melander, C. "Dimeric 2-Aminoimidazoles are Highly Active Adjuvants for Gram-Positive Selective Antibiotics Against Acinetobacter Baumannii" 2023 European Journal of Medicinal Chemistry, 253, 115329. DOI: 10.1016/j.ejmech.2023.115329.